Cargando…
Molecular and functional characterisation of a fusion protein suited for tumour specific prodrug activation.
A fusion protein consisting of the humanised Fab fragment of the anti CEA MAb BW 431 and the human beta-glucuronidase was expressed in BHK cells. Functional testing revealed that the specificity and avidity of the humanised V region was similar to the original murine MAb BW 431. Furthermore, the enz...
Autores principales: | Bosslet, K., Czech, J., Lorenz, P., Sedlacek, H. H., Schuermann, M., Seemann, G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977731/ https://www.ncbi.nlm.nih.gov/pubmed/1739623 |
Ejemplares similares
-
Characterisation of a humanised bispecific monoclonal antibody for cancer therapy.
por: Bruynck, A., et al.
Publicado: (1993) -
Generation of bispecific monoclonal antibodies for two phase radioimmunotherapy.
por: Bosslet, K., et al.
Publicado: (1991) -
Targeting assay of a fusion protein applied in enzyme prodrug therapy
por: Wang, Hao, et al.
Publicado: (2017) -
Characterisation of the Molecular Mechanism of Permeation of the Prodrug Me-5ALA across the Human Stratum Corneum Using Molecular Dynamics Simulations
por: Kadyrov, Janonna, et al.
Publicado: (2022) -
Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours
por: Stone, Thomas J., et al.
Publicado: (2017)